HEADER HYDROLASE 29-DEC-05 2FIE TITLE STRUCTURE OF HUMAN LIVER FBPASE COMPLEXED WITH POTENT BENZOXAZOLE TITLE 2 ALLOSTERIC INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: FRUCTOSE-1,6-BISPHOSPHATASE 1; COMPND 3 CHAIN: A, D, H, L; COMPND 4 EC: 3.1.3.11; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PET29A; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: 6HIS-XPRESS-HUFBP1-PET100-D-TOPO KEYWDS ALLOSTERIC INHIBITORS HUMAN LIVER FBPASE, BENZOXAZOLE, INTERSUBUNIT KEYWDS 2 ALLOSTERIC INHIBITORS OF HUMAN LIVER FBPASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR C.ABAD-ZAPATERO REVDAT 5 30-AUG-23 2FIE 1 REMARK SEQADV REVDAT 4 18-OCT-17 2FIE 1 REMARK REVDAT 3 24-FEB-09 2FIE 1 VERSN REVDAT 2 21-MAR-06 2FIE 1 JRNL REMARK REVDAT 1 21-FEB-06 2FIE 0 JRNL AUTH C.LAI,R.J.GUM,M.DALY,E.H.FRY,C.HUTCHINS,C.ABAD-ZAPATERO, JRNL AUTH 2 T.W.VON GELDERN JRNL TITL BENZOXAZOLE BENZENESULFONAMIDES AS ALLOSTERIC INHIBITORS OF JRNL TITL 2 FRUCTOSE-1,6-BISPHOSPHATASE. JRNL REF BIOORG.MED.CHEM.LETT. V. 16 1807 2006 JRNL REFN ISSN 0960-894X JRNL PMID 16446092 JRNL DOI 10.1016/J.BMCL.2006.01.014 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH T.W.VON GELDERN,C.LAI,R.J.GUM,M.DALY,C.SUN,E.H.FRY, REMARK 1 AUTH 2 C.ABAD-ZAPATERO REMARK 1 TITL BENZOXAZOLE BENZENESULFONAMIDES ARE NOVEL ALLOSTERIC REMARK 1 TITL 2 INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE WITH A DISTINCT REMARK 1 TITL 3 BINDING MODE. REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 16 1811 2006 REMARK 1 REFN ISSN 0960-894X REMARK 1 PMID 16442285 REMARK 1 DOI 10.1016/J.BMCL.2006.01.015 REMARK 2 REMARK 2 RESOLUTION. 2.81 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.81 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 287219.850 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 83.7 REMARK 3 NUMBER OF REFLECTIONS : 32661 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3279 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.90 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 56.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1979 REMARK 3 BIN R VALUE (WORKING SET) : 0.3350 REMARK 3 BIN FREE R VALUE : 0.3980 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 205 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.028 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9728 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 124 REMARK 3 SOLVENT ATOMS : 120 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.62000 REMARK 3 B22 (A**2) : -3.94000 REMARK 3 B33 (A**2) : 6.56000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.35 REMARK 3 LOW RESOLUTION CUTOFF (A) : 8.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.45 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.900 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : GROUP REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 47.28 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : ACCELRYS_CNX_TOPPAR:PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ACCELRYS_CNX_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ACCELRYS_CNX_TOPPAR:ION.PARAM REMARK 3 PARAMETER FILE 4 : 974.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : ION.TOP REMARK 3 TOPOLOGY FILE 3 : 974.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ENTRIES 2FHY, 2FIE AND 2FIX REMARK 3 CHARACTERIZE THE BINDING MODE OF BENZOXAZOLES AS ALLOSTERIC REMARK 3 INHIBITORS OF HUMAN LIVER FBPASE AS DESCRIBED IN THE ASSOCIATED REMARK 3 REFERENCES. THESE THREE ENTRIES FOCUS ON THE BINDING MODE AND REMARK 3 INTERACTIONS IN THE PROXIMITY OF THE LIGANDS. THE MEDIUM TO LOW REMARK 3 RESOLUTION OF THE CRYSTALLOGRAPHIC DATA (3.3, 2.95 AND 2.8 A) REMARK 3 AND THE LIMITED QUALITY AND EXTENT OF THE AVAILABLE DATA, REMARK 3 ESPECIALLY FOR ENTRY 2FIX, SHOULD BE CONSIDERED WHEN TRYING TO REMARK 3 EXTRACT ACCURATE INTERATOMIC DISTANCES BETWEEN THE LIGANDS AND REMARK 3 THE PROTEIN, AT CERTAIN REGIONS OF THE PROTEIN EXPOSED TO REMARK 3 SOLVENT. REMARK 4 REMARK 4 2FIE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-JAN-06. REMARK 100 THE DEPOSITION ID IS D_1000035913. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : SYNCHROTRON REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36725 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.16000 REMARK 200 R SYM (I) : 0.16000 REMARK 200 FOR THE DATA SET : 11.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.45300 REMARK 200 R SYM FOR SHELL (I) : 0.45300 REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: ENTRY 2FHY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS GROWN UNDER OIL (3:1 REMARK 280 PARAFIN:SILICON OIL). 2 UL+2UL DROPS. WELL SOLUTION: 14-18% REMARK 280 PEG1000, 0.1 M TRIS PH 8.0 CRYO: QUICK IMMERSION IN: 16% PEG1000, REMARK 280 20% PEG400,0.1 M TRIS PH 8.0, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.68450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 138.77800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.66350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 138.77800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.68450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.66350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ACTIVE UNIT IS THE TETRAMER. CRYSTAL REMARK 300 CONTAINS FOUR CHAINS IN THE ASYMMETRIC UNIT (A,D,H,L) AND FOUR REMARK 300 MOLECULES OF THE INHIBITORS HERE LABELED AS RESIDUE 974. THE SAME REMARK 300 THING IS TRUE FOR THE RELATED ENTRY 2FHY. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 19640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 43440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -119.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D, H, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 ALA A 1 REMARK 465 ASP A 2 REMARK 465 GLN A 3 REMARK 465 ALA A 4 REMARK 465 PRO A 5 REMARK 465 PHE A 6 REMARK 465 ASP A 7 REMARK 465 THR A 8 REMARK 465 THR A 63 REMARK 465 ASN A 64 REMARK 465 VAL A 65 REMARK 465 THR A 66 REMARK 465 GLY A 67 REMARK 465 ASP A 68 REMARK 465 GLN A 69 REMARK 465 VAL A 70 REMARK 465 LYS A 71 REMARK 465 GLN A 337 REMARK 465 MET D 0 REMARK 465 ALA D 1 REMARK 465 ASP D 2 REMARK 465 GLN D 3 REMARK 465 ALA D 4 REMARK 465 PRO D 5 REMARK 465 PHE D 6 REMARK 465 ASP D 7 REMARK 465 THR D 8 REMARK 465 THR D 63 REMARK 465 ASN D 64 REMARK 465 VAL D 65 REMARK 465 THR D 66 REMARK 465 GLY D 67 REMARK 465 ASP D 68 REMARK 465 GLN D 69 REMARK 465 VAL D 70 REMARK 465 LYS D 71 REMARK 465 GLN D 337 REMARK 465 MET H 0 REMARK 465 ALA H 1 REMARK 465 ASP H 2 REMARK 465 GLN H 3 REMARK 465 ALA H 4 REMARK 465 PRO H 5 REMARK 465 PHE H 6 REMARK 465 ASP H 7 REMARK 465 THR H 8 REMARK 465 THR H 63 REMARK 465 ASN H 64 REMARK 465 VAL H 65 REMARK 465 THR H 66 REMARK 465 GLY H 67 REMARK 465 ASP H 68 REMARK 465 GLN H 69 REMARK 465 VAL H 70 REMARK 465 LYS H 71 REMARK 465 GLN H 337 REMARK 465 MET L 0 REMARK 465 ALA L 1 REMARK 465 ASP L 2 REMARK 465 GLN L 3 REMARK 465 ALA L 4 REMARK 465 PRO L 5 REMARK 465 PHE L 6 REMARK 465 ASP L 7 REMARK 465 THR L 8 REMARK 465 THR L 63 REMARK 465 ASN L 64 REMARK 465 VAL L 65 REMARK 465 THR L 66 REMARK 465 GLY L 67 REMARK 465 ASP L 68 REMARK 465 GLN L 69 REMARK 465 VAL L 70 REMARK 465 LYS L 71 REMARK 465 GLN L 337 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ALA A 336 CA C O CB REMARK 470 ALA D 336 CA C O CB REMARK 470 ALA H 336 CA C O CB REMARK 470 ALA L 336 CA C O CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO L 265 C - N - CA ANGL. DEV. = 9.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 51 -78.57 -38.14 REMARK 500 PHE A 89 33.20 75.00 REMARK 500 LEU A 120 72.21 -162.88 REMARK 500 ILE A 126 0.79 -63.76 REMARK 500 TYR A 164 146.40 -171.91 REMARK 500 ASP A 199 70.00 31.06 REMARK 500 ASN A 236 30.98 31.74 REMARK 500 TYR A 264 72.26 -151.92 REMARK 500 ASN A 267 -138.42 -142.29 REMARK 500 SER A 270 144.21 166.78 REMARK 500 PRO A 271 5.57 -58.59 REMARK 500 GLU A 280 -60.01 -128.82 REMARK 500 LYS D 50 34.39 70.23 REMARK 500 ALA D 51 -90.25 -8.76 REMARK 500 ASN D 125 34.58 -95.97 REMARK 500 ASP D 199 64.72 27.41 REMARK 500 TYR D 215 29.54 -79.67 REMARK 500 PRO D 233 129.40 -37.18 REMARK 500 ASP D 235 15.11 -69.52 REMARK 500 SER D 237 -165.86 -72.17 REMARK 500 ASN D 267 -133.29 174.29 REMARK 500 SER D 270 144.28 155.62 REMARK 500 PRO D 271 28.84 -61.11 REMARK 500 GLU D 280 -57.44 -139.10 REMARK 500 ALA D 314 135.73 -171.63 REMARK 500 SER D 335 -167.60 -115.40 REMARK 500 ALA H 51 -96.40 -20.36 REMARK 500 CYS H 92 -30.56 -130.85 REMARK 500 GLU H 97 -9.12 -58.59 REMARK 500 LEU H 120 78.90 -150.46 REMARK 500 LEU H 129 25.71 48.20 REMARK 500 LEU H 153 48.24 -91.02 REMARK 500 ASP H 199 77.29 40.15 REMARK 500 LEU H 211 145.17 -172.21 REMARK 500 ASP H 235 32.05 -97.30 REMARK 500 ASN H 236 36.56 33.51 REMARK 500 SER H 237 -169.83 -79.97 REMARK 500 TYR H 264 68.45 -154.43 REMARK 500 ASN H 267 -125.13 -162.02 REMARK 500 SER H 270 133.82 151.59 REMARK 500 PRO H 271 4.19 -54.99 REMARK 500 GLU H 280 -59.63 -154.32 REMARK 500 PRO H 307 151.98 -46.19 REMARK 500 ALA L 51 -82.48 -32.50 REMARK 500 CYS L 92 -27.23 -143.75 REMARK 500 ASP L 199 77.36 31.64 REMARK 500 TYR L 215 15.69 -65.17 REMARK 500 TYR L 244 103.39 -165.35 REMARK 500 ALA L 250 -70.44 -56.81 REMARK 500 TYR L 264 68.34 -155.89 REMARK 500 REMARK 500 THIS ENTRY HAS 53 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REGARDING THE LIGAND A74, THE USER SHOULD REFER TO REMARK 600 COMPOUND NO. 48 IN THE MAIN REFERENCE FOR THIS ENTRY, REMARK 600 TABLE 3. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A74 A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A74 D 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A74 H 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A74 L 1001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2FHY RELATED DB: PDB REMARK 900 RELATED ENTRY 2FHY DOCUMENTS THE FIRST COMPOUND OF THE SERIES AT REMARK 900 LOWER RESOLUTION AND WITHOUT SOLVENT DUE TO LIMITED QUALITY AND REMARK 900 EXTEND OF THE DATA REMARK 900 RELATED ID: 2FIX RELATED DB: PDB DBREF 2FIE A 0 337 GB 15277851 AAH12927 1 338 DBREF 2FIE D 0 337 GB 15277851 AAH12927 1 338 DBREF 2FIE H 0 337 GB 15277851 AAH12927 1 338 DBREF 2FIE L 0 337 GB 15277851 AAH12927 1 338 SEQADV 2FIE LYS A 217 GB 15277851 ARG 218 VARIANT SEQADV 2FIE LYS D 217 GB 15277851 ARG 218 VARIANT SEQADV 2FIE LYS H 217 GB 15277851 ARG 218 VARIANT SEQADV 2FIE LYS L 217 GB 15277851 ARG 218 VARIANT SEQRES 1 A 338 MET ALA ASP GLN ALA PRO PHE ASP THR ASP VAL ASN THR SEQRES 2 A 338 LEU THR ARG PHE VAL MET GLU GLU GLY ARG LYS ALA ARG SEQRES 3 A 338 GLY THR GLY GLU LEU THR GLN LEU LEU ASN SER LEU CYS SEQRES 4 A 338 THR ALA VAL LYS ALA ILE SER SER ALA VAL ARG LYS ALA SEQRES 5 A 338 GLY ILE ALA HIS LEU TYR GLY ILE ALA GLY SER THR ASN SEQRES 6 A 338 VAL THR GLY ASP GLN VAL LYS LYS LEU ASP VAL LEU SER SEQRES 7 A 338 ASN ASP LEU VAL MET ASN MET LEU LYS SER SER PHE ALA SEQRES 8 A 338 THR CYS VAL LEU VAL SER GLU GLU ASP LYS HIS ALA ILE SEQRES 9 A 338 ILE VAL GLU PRO GLU LYS ARG GLY LYS TYR VAL VAL CYS SEQRES 10 A 338 PHE ASP PRO LEU ASP GLY SER SER ASN ILE ASP CYS LEU SEQRES 11 A 338 VAL SER VAL GLY THR ILE PHE GLY ILE TYR ARG LYS LYS SEQRES 12 A 338 SER THR ASP GLU PRO SER GLU LYS ASP ALA LEU GLN PRO SEQRES 13 A 338 GLY ARG ASN LEU VAL ALA ALA GLY TYR ALA LEU TYR GLY SEQRES 14 A 338 SER ALA THR MET LEU VAL LEU ALA MET ASP CYS GLY VAL SEQRES 15 A 338 ASN CYS PHE MET LEU ASP PRO ALA ILE GLY GLU PHE ILE SEQRES 16 A 338 LEU VAL ASP LYS ASP VAL LYS ILE LYS LYS LYS GLY LYS SEQRES 17 A 338 ILE TYR SER LEU ASN GLU GLY TYR ALA LYS ASP PHE ASP SEQRES 18 A 338 PRO ALA VAL THR GLU TYR ILE GLN ARG LYS LYS PHE PRO SEQRES 19 A 338 PRO ASP ASN SER ALA PRO TYR GLY ALA ARG TYR VAL GLY SEQRES 20 A 338 SER MET VAL ALA ASP VAL HIS ARG THR LEU VAL TYR GLY SEQRES 21 A 338 GLY ILE PHE LEU TYR PRO ALA ASN LYS LYS SER PRO ASN SEQRES 22 A 338 GLY LYS LEU ARG LEU LEU TYR GLU CYS ASN PRO MET ALA SEQRES 23 A 338 TYR VAL MET GLU LYS ALA GLY GLY MET ALA THR THR GLY SEQRES 24 A 338 LYS GLU ALA VAL LEU ASP VAL ILE PRO THR ASP ILE HIS SEQRES 25 A 338 GLN ARG ALA PRO VAL ILE LEU GLY SER PRO ASP ASP VAL SEQRES 26 A 338 LEU GLU PHE LEU LYS VAL TYR GLU LYS HIS SER ALA GLN SEQRES 1 D 338 MET ALA ASP GLN ALA PRO PHE ASP THR ASP VAL ASN THR SEQRES 2 D 338 LEU THR ARG PHE VAL MET GLU GLU GLY ARG LYS ALA ARG SEQRES 3 D 338 GLY THR GLY GLU LEU THR GLN LEU LEU ASN SER LEU CYS SEQRES 4 D 338 THR ALA VAL LYS ALA ILE SER SER ALA VAL ARG LYS ALA SEQRES 5 D 338 GLY ILE ALA HIS LEU TYR GLY ILE ALA GLY SER THR ASN SEQRES 6 D 338 VAL THR GLY ASP GLN VAL LYS LYS LEU ASP VAL LEU SER SEQRES 7 D 338 ASN ASP LEU VAL MET ASN MET LEU LYS SER SER PHE ALA SEQRES 8 D 338 THR CYS VAL LEU VAL SER GLU GLU ASP LYS HIS ALA ILE SEQRES 9 D 338 ILE VAL GLU PRO GLU LYS ARG GLY LYS TYR VAL VAL CYS SEQRES 10 D 338 PHE ASP PRO LEU ASP GLY SER SER ASN ILE ASP CYS LEU SEQRES 11 D 338 VAL SER VAL GLY THR ILE PHE GLY ILE TYR ARG LYS LYS SEQRES 12 D 338 SER THR ASP GLU PRO SER GLU LYS ASP ALA LEU GLN PRO SEQRES 13 D 338 GLY ARG ASN LEU VAL ALA ALA GLY TYR ALA LEU TYR GLY SEQRES 14 D 338 SER ALA THR MET LEU VAL LEU ALA MET ASP CYS GLY VAL SEQRES 15 D 338 ASN CYS PHE MET LEU ASP PRO ALA ILE GLY GLU PHE ILE SEQRES 16 D 338 LEU VAL ASP LYS ASP VAL LYS ILE LYS LYS LYS GLY LYS SEQRES 17 D 338 ILE TYR SER LEU ASN GLU GLY TYR ALA LYS ASP PHE ASP SEQRES 18 D 338 PRO ALA VAL THR GLU TYR ILE GLN ARG LYS LYS PHE PRO SEQRES 19 D 338 PRO ASP ASN SER ALA PRO TYR GLY ALA ARG TYR VAL GLY SEQRES 20 D 338 SER MET VAL ALA ASP VAL HIS ARG THR LEU VAL TYR GLY SEQRES 21 D 338 GLY ILE PHE LEU TYR PRO ALA ASN LYS LYS SER PRO ASN SEQRES 22 D 338 GLY LYS LEU ARG LEU LEU TYR GLU CYS ASN PRO MET ALA SEQRES 23 D 338 TYR VAL MET GLU LYS ALA GLY GLY MET ALA THR THR GLY SEQRES 24 D 338 LYS GLU ALA VAL LEU ASP VAL ILE PRO THR ASP ILE HIS SEQRES 25 D 338 GLN ARG ALA PRO VAL ILE LEU GLY SER PRO ASP ASP VAL SEQRES 26 D 338 LEU GLU PHE LEU LYS VAL TYR GLU LYS HIS SER ALA GLN SEQRES 1 H 338 MET ALA ASP GLN ALA PRO PHE ASP THR ASP VAL ASN THR SEQRES 2 H 338 LEU THR ARG PHE VAL MET GLU GLU GLY ARG LYS ALA ARG SEQRES 3 H 338 GLY THR GLY GLU LEU THR GLN LEU LEU ASN SER LEU CYS SEQRES 4 H 338 THR ALA VAL LYS ALA ILE SER SER ALA VAL ARG LYS ALA SEQRES 5 H 338 GLY ILE ALA HIS LEU TYR GLY ILE ALA GLY SER THR ASN SEQRES 6 H 338 VAL THR GLY ASP GLN VAL LYS LYS LEU ASP VAL LEU SER SEQRES 7 H 338 ASN ASP LEU VAL MET ASN MET LEU LYS SER SER PHE ALA SEQRES 8 H 338 THR CYS VAL LEU VAL SER GLU GLU ASP LYS HIS ALA ILE SEQRES 9 H 338 ILE VAL GLU PRO GLU LYS ARG GLY LYS TYR VAL VAL CYS SEQRES 10 H 338 PHE ASP PRO LEU ASP GLY SER SER ASN ILE ASP CYS LEU SEQRES 11 H 338 VAL SER VAL GLY THR ILE PHE GLY ILE TYR ARG LYS LYS SEQRES 12 H 338 SER THR ASP GLU PRO SER GLU LYS ASP ALA LEU GLN PRO SEQRES 13 H 338 GLY ARG ASN LEU VAL ALA ALA GLY TYR ALA LEU TYR GLY SEQRES 14 H 338 SER ALA THR MET LEU VAL LEU ALA MET ASP CYS GLY VAL SEQRES 15 H 338 ASN CYS PHE MET LEU ASP PRO ALA ILE GLY GLU PHE ILE SEQRES 16 H 338 LEU VAL ASP LYS ASP VAL LYS ILE LYS LYS LYS GLY LYS SEQRES 17 H 338 ILE TYR SER LEU ASN GLU GLY TYR ALA LYS ASP PHE ASP SEQRES 18 H 338 PRO ALA VAL THR GLU TYR ILE GLN ARG LYS LYS PHE PRO SEQRES 19 H 338 PRO ASP ASN SER ALA PRO TYR GLY ALA ARG TYR VAL GLY SEQRES 20 H 338 SER MET VAL ALA ASP VAL HIS ARG THR LEU VAL TYR GLY SEQRES 21 H 338 GLY ILE PHE LEU TYR PRO ALA ASN LYS LYS SER PRO ASN SEQRES 22 H 338 GLY LYS LEU ARG LEU LEU TYR GLU CYS ASN PRO MET ALA SEQRES 23 H 338 TYR VAL MET GLU LYS ALA GLY GLY MET ALA THR THR GLY SEQRES 24 H 338 LYS GLU ALA VAL LEU ASP VAL ILE PRO THR ASP ILE HIS SEQRES 25 H 338 GLN ARG ALA PRO VAL ILE LEU GLY SER PRO ASP ASP VAL SEQRES 26 H 338 LEU GLU PHE LEU LYS VAL TYR GLU LYS HIS SER ALA GLN SEQRES 1 L 338 MET ALA ASP GLN ALA PRO PHE ASP THR ASP VAL ASN THR SEQRES 2 L 338 LEU THR ARG PHE VAL MET GLU GLU GLY ARG LYS ALA ARG SEQRES 3 L 338 GLY THR GLY GLU LEU THR GLN LEU LEU ASN SER LEU CYS SEQRES 4 L 338 THR ALA VAL LYS ALA ILE SER SER ALA VAL ARG LYS ALA SEQRES 5 L 338 GLY ILE ALA HIS LEU TYR GLY ILE ALA GLY SER THR ASN SEQRES 6 L 338 VAL THR GLY ASP GLN VAL LYS LYS LEU ASP VAL LEU SER SEQRES 7 L 338 ASN ASP LEU VAL MET ASN MET LEU LYS SER SER PHE ALA SEQRES 8 L 338 THR CYS VAL LEU VAL SER GLU GLU ASP LYS HIS ALA ILE SEQRES 9 L 338 ILE VAL GLU PRO GLU LYS ARG GLY LYS TYR VAL VAL CYS SEQRES 10 L 338 PHE ASP PRO LEU ASP GLY SER SER ASN ILE ASP CYS LEU SEQRES 11 L 338 VAL SER VAL GLY THR ILE PHE GLY ILE TYR ARG LYS LYS SEQRES 12 L 338 SER THR ASP GLU PRO SER GLU LYS ASP ALA LEU GLN PRO SEQRES 13 L 338 GLY ARG ASN LEU VAL ALA ALA GLY TYR ALA LEU TYR GLY SEQRES 14 L 338 SER ALA THR MET LEU VAL LEU ALA MET ASP CYS GLY VAL SEQRES 15 L 338 ASN CYS PHE MET LEU ASP PRO ALA ILE GLY GLU PHE ILE SEQRES 16 L 338 LEU VAL ASP LYS ASP VAL LYS ILE LYS LYS LYS GLY LYS SEQRES 17 L 338 ILE TYR SER LEU ASN GLU GLY TYR ALA LYS ASP PHE ASP SEQRES 18 L 338 PRO ALA VAL THR GLU TYR ILE GLN ARG LYS LYS PHE PRO SEQRES 19 L 338 PRO ASP ASN SER ALA PRO TYR GLY ALA ARG TYR VAL GLY SEQRES 20 L 338 SER MET VAL ALA ASP VAL HIS ARG THR LEU VAL TYR GLY SEQRES 21 L 338 GLY ILE PHE LEU TYR PRO ALA ASN LYS LYS SER PRO ASN SEQRES 22 L 338 GLY LYS LEU ARG LEU LEU TYR GLU CYS ASN PRO MET ALA SEQRES 23 L 338 TYR VAL MET GLU LYS ALA GLY GLY MET ALA THR THR GLY SEQRES 24 L 338 LYS GLU ALA VAL LEU ASP VAL ILE PRO THR ASP ILE HIS SEQRES 25 L 338 GLN ARG ALA PRO VAL ILE LEU GLY SER PRO ASP ASP VAL SEQRES 26 L 338 LEU GLU PHE LEU LYS VAL TYR GLU LYS HIS SER ALA GLN HET A74 A 701 31 HET A74 D 801 31 HET A74 H 901 31 HET A74 L1001 31 HETNAM A74 2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1, HETNAM 2 A74 3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE FORMUL 5 A74 4(C20 H15 CL2 N3 O5 S) FORMUL 9 HOH *120(H2 O) HELIX 1 1 THR A 12 ARG A 25 1 14 HELIX 2 2 GLY A 28 ARG A 49 1 22 HELIX 3 3 ALA A 54 GLY A 58 5 5 HELIX 4 4 LYS A 72 SER A 87 1 16 HELIX 5 5 GLY A 122 ILE A 126 5 5 HELIX 6 6 SER A 148 LEU A 153 5 6 HELIX 7 7 PRO A 155 ARG A 157 5 3 HELIX 8 8 ASN A 212 PHE A 219 5 8 HELIX 9 9 ASP A 220 PHE A 232 1 13 HELIX 10 10 SER A 247 GLY A 259 1 13 HELIX 11 11 GLU A 280 ALA A 291 1 12 HELIX 12 12 ALA A 301 VAL A 305 5 5 HELIX 13 13 SER A 320 HIS A 334 1 15 HELIX 14 14 THR D 12 ARG D 25 1 14 HELIX 15 15 GLY D 28 ARG D 49 1 22 HELIX 16 16 GLY D 52 TYR D 57 1 6 HELIX 17 17 LYS D 72 PHE D 89 1 18 HELIX 18 18 GLU D 106 GLU D 108 5 3 HELIX 19 19 GLY D 122 LEU D 129 5 8 HELIX 20 20 SER D 148 LEU D 153 5 6 HELIX 21 21 PRO D 155 ARG D 157 5 3 HELIX 22 22 ASN D 212 PHE D 219 5 8 HELIX 23 23 ASP D 220 PHE D 232 1 13 HELIX 24 24 SER D 247 GLY D 259 1 13 HELIX 25 25 GLU D 280 ALA D 291 1 12 HELIX 26 26 ALA D 301 VAL D 305 5 5 HELIX 27 27 SER D 320 LYS D 333 1 14 HELIX 28 28 THR H 12 ARG H 25 1 14 HELIX 29 29 GLY H 28 ARG H 49 1 22 HELIX 30 30 GLY H 52 TYR H 57 1 6 HELIX 31 31 LYS H 72 PHE H 89 1 18 HELIX 32 32 GLU H 106 GLU H 108 5 3 HELIX 33 33 GLY H 122 LEU H 129 5 8 HELIX 34 34 SER H 148 LEU H 153 5 6 HELIX 35 35 PRO H 155 LEU H 159 5 5 HELIX 36 36 ASN H 212 PHE H 219 5 8 HELIX 37 37 ASP H 220 PHE H 232 1 13 HELIX 38 38 SER H 247 TYR H 258 1 12 HELIX 39 39 GLU H 280 GLY H 292 1 13 HELIX 40 40 ALA H 301 VAL H 305 5 5 HELIX 41 41 SER H 320 HIS H 334 1 15 HELIX 42 42 THR L 12 ARG L 25 1 14 HELIX 43 43 GLY L 28 ARG L 49 1 22 HELIX 44 44 GLY L 52 TYR L 57 5 6 HELIX 45 45 LYS L 72 SER L 88 1 17 HELIX 46 46 GLY L 122 LEU L 129 5 8 HELIX 47 47 SER L 148 LEU L 153 5 6 HELIX 48 48 PRO L 155 LEU L 159 5 5 HELIX 49 49 PRO L 188 GLY L 191 5 4 HELIX 50 50 GLY L 214 PHE L 219 5 6 HELIX 51 51 ASP L 220 PHE L 232 1 13 HELIX 52 52 SER L 247 GLY L 259 1 13 HELIX 53 53 GLU L 280 ALA L 291 1 12 HELIX 54 54 ALA L 301 VAL L 305 5 5 HELIX 55 55 SER L 320 LYS L 333 1 14 SHEET 1 A 8 ILE A 103 ILE A 104 0 SHEET 2 A 8 THR A 91 SER A 96 -1 N LEU A 94 O ILE A 103 SHEET 3 A 8 ARG A 110 ASP A 121 1 O GLY A 111 N THR A 91 SHEET 4 A 8 GLY A 133 ARG A 140 -1 O TYR A 139 N VAL A 114 SHEET 5 A 8 LEU A 159 TYR A 167 -1 O ALA A 161 N ILE A 138 SHEET 6 A 8 THR A 171 ALA A 176 -1 O VAL A 174 N TYR A 164 SHEET 7 A 8 VAL A 181 LEU A 186 -1 O PHE A 184 N LEU A 173 SHEET 8 A 8 PHE A 193 VAL A 200 -1 O ILE A 194 N MET A 185 SHEET 1 B 5 GLY A 241 ALA A 242 0 SHEET 2 B 5 ILE A 208 SER A 210 1 N TYR A 209 O GLY A 241 SHEET 3 B 5 ILE A 261 TYR A 264 1 O LEU A 263 N SER A 210 SHEET 4 B 5 VAL A 316 GLY A 319 -1 O LEU A 318 N PHE A 262 SHEET 5 B 5 MET A 294 THR A 296 -1 N MET A 294 O GLY A 319 SHEET 1 C 8 ILE D 103 ILE D 104 0 SHEET 2 C 8 THR D 91 SER D 96 -1 N LEU D 94 O ILE D 103 SHEET 3 C 8 ARG D 110 ASP D 121 1 O PHE D 117 N VAL D 95 SHEET 4 C 8 VAL D 132 ARG D 140 -1 O TYR D 139 N VAL D 114 SHEET 5 C 8 LEU D 159 TYR D 167 -1 O VAL D 160 N ILE D 138 SHEET 6 C 8 THR D 171 MET D 177 -1 O MET D 172 N LEU D 166 SHEET 7 C 8 GLY D 180 ASP D 187 -1 O LEU D 186 N THR D 171 SHEET 8 C 8 GLU D 192 ASP D 197 -1 O GLU D 192 N ASP D 187 SHEET 1 D 5 GLY D 241 ALA D 242 0 SHEET 2 D 5 ILE D 208 SER D 210 1 N TYR D 209 O GLY D 241 SHEET 3 D 5 ILE D 261 TYR D 264 1 O LEU D 263 N SER D 210 SHEET 4 D 5 VAL D 316 GLY D 319 -1 O VAL D 316 N TYR D 264 SHEET 5 D 5 MET D 294 THR D 296 -1 N MET D 294 O GLY D 319 SHEET 1 E 8 ILE H 103 ILE H 104 0 SHEET 2 E 8 THR H 91 SER H 96 -1 N LEU H 94 O ILE H 103 SHEET 3 E 8 ARG H 110 ASP H 121 1 O VAL H 115 N VAL H 95 SHEET 4 E 8 VAL H 132 ARG H 140 -1 O TYR H 139 N VAL H 114 SHEET 5 E 8 ALA H 161 TYR H 167 -1 O ALA H 161 N ILE H 138 SHEET 6 E 8 THR H 171 ALA H 176 -1 O ALA H 176 N ALA H 162 SHEET 7 E 8 VAL H 181 ASP H 187 -1 O LEU H 186 N THR H 171 SHEET 8 E 8 GLU H 192 ASP H 197 -1 O ILE H 194 N MET H 185 SHEET 1 F 5 GLY H 241 ALA H 242 0 SHEET 2 F 5 ILE H 208 SER H 210 1 N TYR H 209 O GLY H 241 SHEET 3 F 5 ILE H 261 TYR H 264 1 O LEU H 263 N SER H 210 SHEET 4 F 5 VAL H 316 GLY H 319 -1 O LEU H 318 N PHE H 262 SHEET 5 F 5 MET H 294 THR H 296 -1 N THR H 296 O ILE H 317 SHEET 1 G 2 LEU H 275 ARG H 276 0 SHEET 2 G 2 ARG H 313 ALA H 314 -1 O ALA H 314 N LEU H 275 SHEET 1 H 8 ILE L 103 ILE L 104 0 SHEET 2 H 8 THR L 91 SER L 96 -1 N LEU L 94 O ILE L 103 SHEET 3 H 8 TYR L 113 ASP L 121 1 O PHE L 117 N VAL L 95 SHEET 4 H 8 VAL L 132 ARG L 140 -1 O TYR L 139 N VAL L 114 SHEET 5 H 8 ALA L 161 TYR L 167 -1 O TYR L 167 N VAL L 132 SHEET 6 H 8 THR L 171 MET L 177 -1 O ALA L 176 N ALA L 162 SHEET 7 H 8 VAL L 181 ASP L 187 -1 O PHE L 184 N LEU L 173 SHEET 8 H 8 GLU L 192 ASP L 197 -1 O ILE L 194 N MET L 185 SHEET 1 I 5 GLY L 241 ALA L 242 0 SHEET 2 I 5 ILE L 208 SER L 210 1 N TYR L 209 O GLY L 241 SHEET 3 I 5 ILE L 261 TYR L 264 1 O LEU L 263 N SER L 210 SHEET 4 I 5 VAL L 316 GLY L 319 -1 O LEU L 318 N PHE L 262 SHEET 5 I 5 MET L 294 THR L 296 -1 N THR L 296 O ILE L 317 SITE 1 AC1 17 VAL A 17 GLY A 21 ARG A 22 ALA A 24 SITE 2 AC1 17 ARG A 25 GLY A 26 THR A 27 GLY A 28 SITE 3 AC1 17 GLU A 29 LEU A 30 THR A 31 LEU A 34 SITE 4 AC1 17 MET A 177 HOH A 517 GLY L 26 THR L 27 SITE 5 AC1 17 A74 L1001 SITE 1 AC2 15 VAL D 17 GLY D 21 ALA D 24 ARG D 25 SITE 2 AC2 15 GLY D 26 THR D 27 GLY D 28 GLU D 29 SITE 3 AC2 15 LEU D 30 THR D 31 HOH D 510 GLY H 26 SITE 4 AC2 15 THR H 27 THR H 31 A74 H 901 SITE 1 AC3 15 GLY D 26 THR D 27 A74 D 801 VAL H 17 SITE 2 AC3 15 GLY H 21 ARG H 22 ALA H 24 ARG H 25 SITE 3 AC3 15 GLY H 26 THR H 27 GLY H 28 GLU H 29 SITE 4 AC3 15 LEU H 30 THR H 31 HOH H 616 SITE 1 AC4 17 GLY A 26 THR A 27 GLY A 28 A74 A 701 SITE 2 AC4 17 VAL L 17 GLY L 21 ARG L 22 ALA L 24 SITE 3 AC4 17 ARG L 25 GLY L 26 THR L 27 GLY L 28 SITE 4 AC4 17 GLU L 29 LEU L 30 THR L 31 MET L 177 SITE 5 AC4 17 HOH L 516 CRYST1 67.369 83.327 277.556 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014844 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012001 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003603 0.00000